Most lately, it's been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar regions as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor acts as being a scavenger https://neilt208yzb9.wikinewspaper.com/user